In defiance of FTC and EU scrutiny, Illumina Inc (NASDAQ: ILMN) went ahead to complete its billion acquisition of Grail. The finalization of the buyout comes as the FTC sued to block the move in March ...

Illumina (ILMN) just deepened its bet on clinical whole genome sequencing by investing in and partnering with MyOme, backing a large Proactive Health trial that blends sequencing with AI driven risk ...

The General Court of the European Union ruled Wednesday that the European Commission can proceed with its review of the Illumina (NASDAQ:ILMN) acquisition of Grail. Illumina lost its challenge in ...

Proteomics enables the observation of direct cellular function to gain insights on protein-driven disease traits. (Image Credits: Pixabay) Illumina, Inc. on Monday announced that it will present ...